New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 25, 2013
06:53 EDTTHRXTheravance upgraded to Outperform from Market Perform at Bernstein
Bernstein upgraded Theravance and views risk/reward as favorable ahead of Relvar and Anoro FDA/EMA decisions this year. Price target is $26.
News For THRX From The Last 14 Days
Check below for free stories on THRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 26, 2014
20:12 EDTTHRXTheravance looks overvalued, Barron's says
Subscribe for More Information
July 24, 2014
10:03 EDTTHRXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:32 EDTTHRXTheravance downgraded at BofA/Merrill
Subscribe for More Information
06:07 EDTTHRXTheravance downgraded to Neutral from Buy at BofA/Merrill
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use